Logo image of MRX.DE

MISTER SPEX SE (MRX.DE) Stock Fundamental Analysis

FRA:MRX - Deutsche Boerse Ag - DE000A3CSAE2 - Common Stock - Currency: EUR

1.5  +0 (+0.33%)

Fundamental Rating

2

Taking everything into account, MRX scores 2 out of 10 in our fundamental rating. MRX was compared to 54 industry peers in the Specialty Retail industry. The financial health of MRX is average, but there are quite some concerns on its profitability. MRX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MRX has reported negative net income.
In the past year MRX has reported a negative cash flow from operations.
MRX had negative earnings in each of the past 5 years.
In multiple years MRX reported negative operating cash flow during the last 5 years.
MRX.DE Yearly Net Income VS EBIT VS OCF VS FCFMRX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

MRX's Return On Assets of -23.46% is on the low side compared to the rest of the industry. MRX is outperformed by 85.19% of its industry peers.
Looking at the Return On Equity, with a value of -44.25%, MRX is doing worse than 81.48% of the companies in the same industry.
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROIC N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
MRX.DE Yearly ROA, ROE, ROICMRX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

The Gross Margin of MRX (52.57%) is better than 77.78% of its industry peers.
In the last couple of years the Gross Margin of MRX has grown nicely.
MRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
MRX.DE Yearly Profit, Operating, Gross MarginsMRX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

MRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRX has been increased compared to 1 year ago.
MRX has more shares outstanding than it did 5 years ago.
MRX has a worse debt/assets ratio than last year.
MRX.DE Yearly Shares OutstandingMRX.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
MRX.DE Yearly Total Debt VS Total AssetsMRX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

MRX has an Altman-Z score of -0.52. This is a bad value and indicates that MRX is not financially healthy and even has some risk of bankruptcy.
MRX has a Altman-Z score of -0.52. This is in the lower half of the industry: MRX underperforms 72.22% of its industry peers.
MRX has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MRX (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC5.15%
MRX.DE Yearly LT Debt VS Equity VS FCFMRX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

MRX has a Current Ratio of 3.04. This indicates that MRX is financially healthy and has no problem in meeting its short term obligations.
MRX has a better Current ratio (3.04) than 90.74% of its industry peers.
A Quick Ratio of 2.24 indicates that MRX has no problem at all paying its short term obligations.
The Quick ratio of MRX (2.24) is better than 90.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.24
MRX.DE Yearly Current Assets VS Current LiabilitesMRX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

MRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.77%.
The Revenue has been growing slightly by 1.30% in the past year.
The Revenue has been growing by 12.73% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%

3.2 Future

The Earnings Per Share is expected to grow by 14.00% on average over the next years. This is quite good.
MRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.66% yearly.
EPS Next Y-86.57%
EPS Next 2Y2.85%
EPS Next 3Y13.18%
EPS Next 5Y14%
Revenue Next Year-2.59%
Revenue Next 2Y-5.08%
Revenue Next 3Y-2.37%
Revenue Next 5Y8.66%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRX.DE Yearly Revenue VS EstimatesMRX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MRX.DE Yearly EPS VS EstimatesMRX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRX.DE Price Earnings VS Forward Price EarningsMRX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRX.DE Per share dataMRX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as MRX's earnings are expected to grow with 13.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.85%
EPS Next 3Y13.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MISTER SPEX SE

FRA:MRX (5/26/2025, 7:00:00 PM)

1.5

+0 (+0.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2024-05-08/amc
Earnings (Next)N/A N/A
Inst Owners25.4%
Inst Owner ChangeN/A
Ins Owners3.98%
Ins Owner ChangeN/A
Market Cap52.58M
Analysts77.5
Price Target4.23 (182%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-1.65
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS6.37
BVpS3.56
TBVpS2.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.46%
ROE -44.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.57%
FCFM N/A
ROA(3y)-14.03%
ROA(5y)-11.64%
ROE(3y)-22.01%
ROE(5y)-25.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y1.76%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.75%
Cap/Sales 3.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.04
Quick Ratio 2.24
Altman-Z -0.52
F-Score4
WACC5.15%
ROIC/WACCN/A
Cap/Depr(3y)72.39%
Cap/Depr(5y)88.93%
Cap/Sales(3y)8.02%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.86%
EPS Next Y-86.57%
EPS Next 2Y2.85%
EPS Next 3Y13.18%
EPS Next 5Y14%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y10.83%
Revenue growth 5Y12.73%
Sales Q2Q%-3.17%
Revenue Next Year-2.59%
Revenue Next 2Y-5.08%
Revenue Next 3Y-2.37%
Revenue Next 5Y8.66%
EBIT growth 1Y-25.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.11%
EBIT Next 3Y32.33%
EBIT Next 5Y28.78%
FCF growth 1Y48.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.05%
OCF growth 3YN/A
OCF growth 5YN/A